Neutrogena Rapid Clear Acne Eliminating Spot

Description

NEUTROGENA Rapid Clear® Acne Eliminating Spot Gel is formulated with MICRO CLEAR® technology and contains salicylic acid, a recognized active ingredient for acne treatment. The product is presented in a dosage form of a gel and is packaged in a 0.5 fluid ounce (15 mL) container.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The recommended application involves covering the entire affected area with a thin layer. This can be done one to three times daily, depending on the patient's needs and the physician's guidance.

It is advisable to initiate treatment with one application per day to minimize the risk of excessive drying of the skin. Based on the patient's response, the frequency may be gradually increased to two or three times daily as necessary or as directed by a healthcare provider.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the frequency of application to once a day or every other day to alleviate these side effects.

Contraindications

Use of this product is contraindicated in the following situations:

• The product should be kept out of reach of children to prevent accidental ingestion.

• In the event of accidental swallowing, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame to prevent any risk of ignition.

It is imperative to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Users should be aware that the likelihood of skin irritation and dryness increases when this product is used concurrently with other topical acne medications. To minimize the risk of irritation, it is recommended to use only one topical medication at a time.

In case of contact with the eyes, it is essential to flush the eyes thoroughly with water to remove any residual product and reduce the risk of irritation or injury.

Side Effects

Patients using this product should be aware that it is intended for external use only. The product is flammable; therefore, it should be kept away from fire or flame to prevent any hazardous situations.

During the use of this topical medication, skin irritation and dryness may occur, particularly if another topical acne medication is used concurrently. It is advisable for patients to limit the use of topical medications to one at a time to minimize the risk of irritation. In the event of eye contact, patients should flush the affected area thoroughly with water to alleviate any discomfort.

In cases where the product is ingested, immediate medical assistance should be sought, or patients should contact a Poison Control Center without delay.

Drug Interactions

The concurrent use of topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical medication be used at a time. If irritation occurs, discontinuation of one of the topical agents is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when multiple topical treatments are considered.

Packaging & NDC

Below are the non-prescription pack sizes of Neutrogena Rapid Clear Acne Eliminating Spot (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of Neutrogena Rapid Clear Acne Eliminating Spot Gel, as the drug insert does not provide details on dosage adjustments, safety concerns, or special precautions for this population.

Healthcare providers should exercise caution when prescribing this product to geriatric patients, considering the absence of targeted clinical findings or recommendations. Monitoring for any adverse effects or unusual reactions is advisable, given the lack of established safety data in this demographic.

Pregnancy

The safety of Neutrogena Rapid Clear Acne Eliminating Spot Gel during pregnancy has not been established, as the prescribing information does not provide specific data regarding its use in pregnant patients. There are no documented safety concerns, dosage modifications, or special precautions outlined for this product in the context of pregnancy. Healthcare professionals should exercise caution when recommending this product to women of childbearing potential and consider the lack of available data when assessing the risks and benefits for pregnant patients.

Lactation

There are no specific warnings or recommendations regarding the use of Neutrogena Rapid Clear Acne Eliminating Spot Gel in lactating mothers. Additionally, there is no information available about the potential for excretion of the product in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of data does not preclude the need for careful evaluation and monitoring in this population.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact a Poison Control Center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action and management strategies.

Healthcare providers should ensure that patients are aware of the importance of timely reporting of any suspected overdosage to facilitate effective treatment and minimize risks.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available for Neutrogena Rapid Clear Acne Eliminating Spot Gel (SPL code 90375-7).

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed that the use of this medication may lead to skin irritation and dryness, particularly if they are using another topical acne medication concurrently. It is recommended that patients use only one topical medication at a time to minimize the risk of irritation.

Additionally, healthcare providers should instruct patients on the importance of avoiding eye contact with the medication. If contact occurs, patients should be advised to flush the eyes thoroughly with water to ensure safety and reduce potential discomfort.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. Proper handling should be observed to ensure optimal conditions are met throughout the storage period.

Additional Clinical Information

The product is administered topically. Clinicians should counsel patients regarding the potential for increased skin sensitivity to the sun due to the presence of an alpha hydroxy acid (AHA) in the formulation. Patients are advised to use sunscreen, wear protective clothing, and limit sun exposure while using the product and for one week following its use. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Neutrogena Rapid Clear Acne Eliminating Spot, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)